A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing–remitting multiple sclerosis - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Neurology Année : 2023

A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing–remitting multiple sclerosis

Fichier non déposé

Dates et versions

hal-04493282 , version 1 (07-03-2024)

Identifiants

Citer

C. Louapre, M. Rosenzwajg, M. Golse, A. Roux, F. Pitoiset, et al.. A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing–remitting multiple sclerosis. Journal of Neurology, 2023, 270 (9), pp.4403-4414. ⟨10.1007/s00415-023-11690-6⟩. ⟨hal-04493282⟩
10 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More